Skip to content
INVEST IN THE FUTURE OF OPEN SURGERY

Now surgeons can see blood flow while working on blood vessels—safely, seamlessly.

… with Viewflow smart camera.

It’s redefining how millions of operations a year are done, with top surgeons ready to deploy.

Why Invest? Straight Talk

Surgeons can’t reliably see live blood flow during surgery because their options are limited.

Giving surgeons real-time “vision” into blood vessel flow may help reduce their time, patient complications, and costs.

For you, it’s a chance to back something meaningful with real clinical and financial upsides.

Massive Problem
1 in 5 bypass grafts end up with poor flow. 1 in 7 reconstruction flaps fail completely – tissue dies.

The #1 problem surgeons face is knowing if the procedure ends with adequate blood flow.

Dr. Vip Patel, 19,000 robotics surgeries

Easy Breakthrough
Point the camera. See live vessel flow – a world first: no dyes, no probes, or no x-rays.

After seeing this level of information, it would be difficult to operate without it

Chief Heart Surgeon, Dr. Theodoro

Goals
Performance of Novadaq (dye)
Same surgeons, same workflow, no dye
Grow at 50%. Exit 3-4 yrs at 10–22x sales

Chart excludes 2008–2010 U.S. financial crisis (Years 2–3)

Traction & Money Path

FDA Surgical Camera.
Multiple hospitals ready for clinical programs (including a major UNC‑network system).
ViewFlow can share in savings to payers and hospitals where it saves costly complications or insulates against legal liability.

Team That Delivers

Pros who’ve built and sold health‑tech products.

Jim Sund, PhD, CEO
NASA Fellow | Commercialized health-tech to Roche & Merck

Proven Path to Market & Exit

Randall Wolf, MD
DeBakey Heart Center

Data‑driven wins

Kimberly Steinmann, MD
Clinical Studies Lead Advisor

Useful for many procedures

Dennis Robbins, PhD, MPH
Chief Strategy & Payment Advisor and National Thought Leader

What Investors Are Saying

Investing in ViewFlow was easy and exciting.

I love knowing my money helps real people recover faster.

Viewflow may well change the standard of care.

Safer, smarter, and seamless.

Join Series A

Final $600K of $5M to ship to collaborators

Clinical Collaborations

Engaging with leading academic medical centers

Back To Top